Washington Examiner
Sign in
SUBSCRIBE
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Authors › Posts by Linda Johnson

Linda Johnson

Read the latest stories and analysis from Linda Johnson.

Business

Women: J&J trashed records in product injury suits

Linda Johnson · March 26, 2014 5:39 pm
Business

Study: Pfizer vaccine cuts pneumonia in elderly

Linda Johnson · March 12, 2014 6:19 pm
Business

Pfizer stock trades halted over drug patent ruling

Linda Johnson · March 12, 2014 5:36 pm
Business

Hospitals coping better as drug shortages persist

Linda Johnson · February 27, 2014 8:51 pm
Business

Bayer clotting drug meets late-stage study’s goal

Linda Johnson · February 18, 2014 11:12 pm
Business

Merck, partners to jointly test hot cancer drug

Linda Johnson · February 5, 2014 6:33 pm
In this Thursday, Feb. 28, 2013 photo, a Merck logo is placed on scientist's lab coat in West Point, Pa. Merck & Co. reports quarterly financial results before the market opens on Wednesday, Feb. 5, 2014. (AP Photo/Matt Rourke) Business

Merck Q4 net drops 14 pct. on generic competition

Linda Johnson · February 5, 2014 4:25 pm
Business

NIH, drugmakers, foundations partner to find meds

Linda Johnson · February 4, 2014 8:16 pm
Business

Pfizer breast cancer drug hits midstage study goal

Linda Johnson · February 3, 2014 9:12 pm
FILE - This April 20, 2010, file photo,shows an exterior view of Amgen offices in Fremont, Calif.  Biotech drugmaker Amgen Inc. reports quarterly earnings on Tuesday, Jan. 28, 2014.AP Photo/Paul Sakuma, file) Business

Amgen 4Q profit leaps 30 percent on higher sales

Linda Johnson · January 29, 2014 12:26 am
FILE - In this Jan. 30, 2012 file photo, boxes of the drug Relpax, made by Pfizer, are displayed in Surfside, Fla. Pfizer reports quarterly results before the market open on Tuesday, Jan. 28, 2014. (AP Photo/Wilfredo Lee, File) Business

Pfizer’s 4Q net plunges on charges, sales decline

Linda Johnson · January 28, 2014 7:02 pm
Business

Sales up, 4th-quarter net falls for Bristol-Myers

Linda Johnson · January 24, 2014 10:48 pm
Advertisement
  • ‹Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 10
  • ›Next page
Page 3 of 10
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement